EUVIMEDEUVIMED entdecken
Crossref

Carbohydrate antigen 125-guided pre-TAVI medical optimization: impact on quality of life and clinical outcomes

Sergio García-Blas, Vicente Pernias, Jessika González D'Gregorio, Agustín Fernández-Cisnal, Clara Bonanad, Clara Sastre, Ernesto Valero, Gema Miñana, Georgiana Zaharia, Julio Núñez, Juan Sanchis

Revista Española de Cardiología (English Edition) · 2024

DOI: 10.1016/j.rec.2024.01.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Española de Cardiología (English Edition), 2024. Verfasst von Sergio García-Blas und 10 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Cardiología, Hospital Clínico Universitario de Valencia, Valencia, Spain; Instituto de Investigación Sanitaria (INCLIVA), Valencia, Spain…. Hauptthemen laut MEDLINE: Quality of Life, CA-125 Antigen, Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND OBJECTIVES: Carbohydrate antigen 125 (CA125), a biomarker associated with fluid overload, has proven useful in managing diuretic therapy in heart failure. We aimed to evaluate the impact of diuretic optimization guided by CA125 before transcatheter aortic valve implantation (TAVI) on outcomes. METHODS: This prospective interventional study enrolled patients scheduled for TAVI, in whom baseline CA125 was measured 2 weeks before TAVI. Patients with CA125 ≥ 20 U/mL underwent diuretic up-titration before TAVI. Three groups were included: group I) baseline CA125

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeCA-125 AntigenTranscatheter Aortic Valve ReplacementAortic Valve StenosisHumansMaleFemaleProspective StudiesAged, 80 and overBiomarkersDiureticsTreatment OutcomeAgedFollow-Up Studies

Stichwörter der Autor:innen

Aortic valve stenosisBiomarcadoresBiomarkersEstenosis de la válvula aórticaImplante percutáneo de válvula aórticaTranscatheter aortic valve implantation

Substanzen

CA-125 AntigenBiomarkersDiuretics

Autor:innen und Institutionen

  • Servicio de Cardiología, Hospital Clínico Universitario de Valencia, Valencia, Spain; Instituto de Investigación Sanitaria (INCLIVA), Valencia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovascu…
  • Servicio de Cardiología, Hospital General de Castellón, Castellón, Spain.
  • Servicio de Cardiología, Hospital Universitario de Torrevieja, Torrevieja, Alicante, Spain.
  • Servicio de Cardiología, Hospital Francesc de Borja, Gandía, Valencia, Spain.
  • Instituto de Investigación Sanitaria (INCLIVA), Valencia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain.

Förderung

  • Ministerio de Ciencia e Innovación
  • Instituto de Salud Carlos III
  • European Regional Development Fund

Zitieren

APA

García-Blas, S., Pernias, V., González D'Gregorio, J., Fernández-Cisnal, A., Bonanad, C., Sastre, C., Valero, E., Miñana, G., Zaharia, G., Núñez, J., & Sanchis, J. (2024). Carbohydrate antigen 125-guided pre-TAVI medical optimization: impact on quality of life and clinical outcomes. Revista Española de Cardiología (English Edition). https://doi.org/10.1016/j.rec.2024.01.002

Vancouver

García-Blas S, Pernias V, González D'Gregorio J, Fernández-Cisnal A, Bonanad C, Sastre C, et al. Carbohydrate antigen 125-guided pre-TAVI medical optimization: impact on quality of life and clinical outcomes. Revista Española de Cardiología (English Edition). 2024. doi:10.1016/j.rec.2024.01.002

BibTeX
@article{GarcaBlas2024,
  author = {García-Blas, Sergio and Pernias, Vicente and González D'Gregorio, Jessika and Fernández-Cisnal, Agustín and Bonanad, Clara and Sastre, Clara and Valero, Ernesto and Miñana, Gema and Zaharia, Georgiana and Núñez, Julio and Sanchis, Juan},
  title = {Carbohydrate antigen 125-guided pre-TAVI medical optimization: impact on quality of life and clinical outcomes},
  journal = {Revista Española de Cardiología (English Edition)},
  year = {2024},
  doi = {10.1016/j.rec.2024.01.002}
}
Kostenlos starten →